Skip to main content

Table 2 Intraoperative data and postoperative outcomes

From: Surgical treatment of infective endocarditis in active intravenous drug users: a justified procedure?

 

90-d survivors

90-d non-survivors

p-value

Vegetation size (mm)

23.5 ± 8.7

35 ± 7.1

0.099

Bypass time (min)

130.4 ± 70.9

219.5 ± 120.9

0.126

Cross clamp time (min)

86.7 ± 44.4

136 ± 84.9

0.189

Operation duration (min)

219 ± 78

385 ± 148

0.016

Type of valve surgery

  

0.189

Mechanical prosthesis

11 (61.1%)

0

 

Biological prosthesis

6 (33.3%)

2 (100%)

 

Reconstruction

1 (5.6%)

0

 

Site of valve surgery

  

0.113

Aortic

4 (22.2%)

0

 

Mitral

2 (11.1%)

0

 

Tricuspid

7 (38.9%)

1 (50%)

 

Aortic and mitral

2 (11.1%)

0

 

Aortic and tricuspid

1 (5.6%)

0

 

Mitral and tricuspid

2 (11.1%)

0

 

Aortic, mitral and pulmonary

0

1 (50%)

 

Multivalve surgery

5 (27.8%)

1 (50%)

0.521

RBC (mL)

1267 ± 883

2900 ± 141

0.020

FFP (mL)

433 ± 441

200 ± 283

0.479

Platelets (mL)

267 ± 305

440 ± 622

0.503

Atrial fibrillation

11 (61.1%)

2 (100%)

0.521

AV-block

4 (23.5%)

1 (50%)

0.468

Permanent pacemaker

2 (11.8%)

0

1.000

Renal failure

5 (27.8%)

2 (100%)

0.111

Coagulation disorder

3 (17.6%)

1 (50%)

0.386

Reopening for bleeding

0

0

 

CVA

0

0

 
  1. RBC, red blood cells; FFP, fresh frozen plasma; CVA, cerebrovascular accident.